- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02771652
Effect of an Internet-based At-home Physical Training Protocol on Quality of Life, Fatigue, Functional Performance, Aerobic Capacity and Muscle Strength in Multiple Sclerosis Patients (ms-intakt)
June 23, 2016 updated by: Prof. Dr. Klaus Pfeifer, University of Erlangen-Nürnberg
In this randomised controlled trial, the feasibility and effectiveness of an internet-based exercise intervention including progressive strength and endurance training (e-training) for PwMS was investigated.
Primary outcome was health-related quality of life, secondary outcomes were muscle strength, aerobic capacity and lung function, physical activity and fatigue.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
126
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- diagnosed Multiple Sclerosis (McDonald criteria),
- an EDSS score of less than or equal to 4.0,
- not less than 4 weeks of clinical stability prior to inclusion in the study,
- access to the internet.
- the taking of immunotherapeutic agents was not relevant and not monitored
Exclusion Criteria:
- primary progressive multiple sclerosis
- clinically relevant internal disease, especially cardiovascular or pulmonary disease, metabolic and orthopedic diseases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: e-training intervention
Resistance and endurance training
|
The e-training intervention is a home-based aerobic and resistance training program.
Resistance training was prescribed twice weekly for a period of 12 weeks.
No special equipment was necessary except an elastic exercise band or a large gymnastic ball.
In addition, endurance training was to be carried out once a week.
Training intensity was regulated by the participant's subjective, perceived exertion, which was rated between 6 and 20 on the BORG Scale.
The form of activity for the endurance training was freely selected, duration (between 10-60 min) was adjusted to individual fitness levels.
Therapists aimed at eliciting a BORG Feedback of between 11 (fairly light) and 16 (hard).
The exercise training was home-based and supervised via the internet.
Participants continued exercise training for another 12 weeks after the 3month assessment.
|
|
Other: Control
no exercise
|
After the initial assessment on entry, those assigned to the control group were instructed to maintain their previous physical activity behaviour.
After waiting three months, they received the same e-training intervention as the intervention group had received from the start.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Hamburg Quality of Life Questionnaire for Multiple Sclerosis (HAQUAMS)
Time Frame: Assessments took place at baseline and at 3 months
|
38 items generate the subscales of fatigue/thinking, mobility of the lower/upper extremities, communication and mood.
The HAQUAMS total score is calculated from a mean of the subscales, providing a total score between 1 and 5. Higher scores in HAQUAMS indicate lower levels in HRQoL.
The primary outcome will be the change over time from baseline to month 3.
|
Assessments took place at baseline and at 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Würzburg Fatigue Scale (WEIMuS)
Time Frame: Assessments took place at baseline, at 3 and 6 months
|
This questionnaire contains 17 items that form a physical and cognitive subscale.
The total score ranges from zero to a maximum of 68 points (maximum fatigue).
The cut-off value for the presence of fatigue is above 32.
|
Assessments took place at baseline, at 3 and 6 months
|
|
Muscle strength lower extremities
Time Frame: Assessments took place at baseline and after 3 and 6 months
|
Maximum isometric muscle strength was tested with the M3 Diagnos machine (Schnell, Peutenhausen, Germany).
|
Assessments took place at baseline and after 3 and 6 months
|
|
Forced vital capacity
Time Frame: Assessments took place at baseline and after 3 and 6 months
|
Forced vital capacity (FVC) was tested with the Master Screen CPX System (Viasys Healthcare, Cardinal Health, Germany).
|
Assessments took place at baseline and after 3 and 6 months
|
|
Aerobic capacity
Time Frame: Assessments took place at baseline and after 3 and 6 months
|
As a marker of endurance capacity, maximal oxygen uptake (VO2peak) was determined by the spiroergometry device Master Screen CPX on a bicycle ergometer (Sanabike 250F, MESA, Germany) at 70-80 revolutions per minute.
|
Assessments took place at baseline and after 3 and 6 months
|
|
Physical activity
Time Frame: Assessments took place at baseline and after 3 and 6 months
|
Habitual physical activity was assessed with the German version of the Baecke Questionnaire including three activity indices (work, sport, leisure time PA).
There were limitations concerning content validity in all indices; therefore, the sport score of the sport index was used.
That score is the product of the intensity, duration and frequency of a participant's reported sports activities.
Higher scores indicate a higher level of PA.
|
Assessments took place at baseline and after 3 and 6 months
|
|
Peak expiratory flow
Time Frame: Assessments took place at baseline and after 3 and 6 months
|
Peak expiratory flow (PEF) was tested with the Master Screen CPX System (Viasys Healthcare, Cardinal Health, Germany).
|
Assessments took place at baseline and after 3 and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Matthias Mäurer, Dr., Caritas-Krankenhaus Bad Mergentheim
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Tallner A, Tzschoppe R,Peters S, Mäurer M, Pfeifer K. Internetgestützte Bewegungsförderung bei Personen mit Multipler Sklerose. Neurologie und Rehabilitation 19(1): 35-46, 2013.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Actual)
June 1, 2011
Study Completion (Actual)
November 1, 2011
Study Registration Dates
First Submitted
May 4, 2016
First Submitted That Met QC Criteria
May 10, 2016
First Posted (Estimate)
May 13, 2016
Study Record Updates
Last Update Posted (Estimate)
June 24, 2016
Last Update Submitted That Met QC Criteria
June 23, 2016
Last Verified
June 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1.01.1/09/007
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Study Data/Documents
-
Detailed intervention description
Information comments: Detailed description of the processes of the e-training intervention (english language)
-
Clinical Study Report
Information comments: Final report for funding foundation (german)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Multiple Sclerosis
-
University Hospital, Basel, SwitzerlandSwiss National Science FoundationRecruitingMultiple Sclerosis (MS) | Relapsing-remitting Multiple Sclerosis (RRMS) | Secondary-progressive Multiple Sclerosis (SPMS) | Primary Progressive Multiple Sclerosis (PPMS)Switzerland
-
University of California, Los AngelesUnknownRelapsing-remitting Multiple Sclerosis | Secondary-progressive Multiple Sclerosis | Primary-progressive Multiple SclerosisUnited States
-
BiogenCompletedMultiple Sclerosis | Relapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Multiple Sclerosis, Primary Progressive | Multiple Sclerosis, Remittent ProgressiveJapan
-
Cabaletta BioNot yet recruitingProgressive Multiple Sclerosis | Multiple Sclerosis | Multiple Sclerosis (Relapsing Remitting) | Relapsing Multiple Sclerosis (RMS) | Progressive Multiple Sclerosis (PMS) | Multiple Sclerosis (MS) - Relapsing-remitting | Multiple Sclerosis - Relapsing Remitting
-
The Cleveland ClinicUniversity Hospitals Cleveland Medical CenterCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple Sclerosis | Progressive Relapsing Multiple SclerosisUnited States
-
Icahn School of Medicine at Mount SinaiColumbia University; New York Stem Cell Foundation Research InstituteCompletedClinically Isolated Syndrome | Relapsing-Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
Rigshospitalet, DenmarkOdense University Hospital; Aarhus University Hospital; Hvidovre University Hospital and other collaboratorsActive, not recruitingRelapsing Remitting Multiple Sclerosis | Primary Progressive Multiple Sclerosis | Secondary Progressive Multiple SclerosisDenmark
-
Novartis PharmaceuticalsCompletedRelapsing-remitting Multiple Sclerosis | Active Secondary Progressive Multiple SclerosisJapan
-
Banc de Sang i TeixitsVall d'Hebron Research Institute (VHIR)CompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisSpain
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
Clinical Trials on e-training
-
University of CagliariRecruiting
-
University GhentCompletedSuicidal Ideation | SuicideBelgium
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)WithdrawnObesity | Overweight | Craving | Eating BehaviorUnited States
-
IWK Health CentreLaval University; Canadian Association of Fire ChiefsActive, not recruiting
-
Medical University of ViennaWithdrawnHeart Arrest | Virtual RealityAustria
-
Oslo University HospitalNorwegian Nurses Organisation; Sophies Minde Ortopedi ASCompleted
-
Mental Health Society of GhanaColumbia University; World Health Organization; University of Cagliari; Mental...Completed
-
National Taiwan University HospitalUnknownStroke | Motor Deficit | Feedback, PsychologicalTaiwan
-
The Hong Kong Polytechnic UniversityTung Wah College; Hospital Authority, Hong KongRecruitingFrailty | Mild Cognitive ImpairmentHong Kong
-
Norwegian University of Science and TechnologyUniversity of OsloCompleted